In Vitro Diagnostics Market - A Hotspot For Venture Capital Funding

London, United Kingdom (PressExposure) December 16, 2009 -- The global In Vitro Diagnostics (IVD) market, valued at $33.89 billion in 2008, has seen increased private equity/venture capital funding over the past two years. There were 77 deals in this market, higher than any of the medical equipment markets, signifying the rapid growth expected in this market, and the relative stability of this market in the face of global recession.

The IVD market, driven by high disease incidences and a demand for better and faster methods of diagnosis, is expected to grow at a rate of 7.1% over the 2008–2015 period, to reach a value of $58.46 billion in 2015. The IVD market presents a lucrative investment opportunity within the diagnostic spectrum, a fact that is reiterated by the rise in the number of deals in this sector.

This analysis was taken from a research paper published by GlobalData, to download the full Research Paper for free, click below:

Access the latest In Vitro Diagnostics analysis for free at


ResearchViews is your number one portal for industry related news, research, analysis and deals data. ResearchViews offers up to the minute content produced by an expert team of industry analysts.

All content on the site is free to view and allows users to keep up to date with the latest developments in their chosen industry. Free daily and weekly newsletters provide a snapshot of the major issues affecting the industry. The site also features a research store, providing the user with access to premium business intelligence from some of the world's leading market research publishers.

About GlobalData

GlobalData is a global market intelligence services company providing information research and analysis products and services.

Press Release Source:

Press Release Submitted On: December 16, 2009 at 2:53 am
This article has been viewed 14142 time(s).